Amed Co., Ltd.(TW:7575)
TW:7575
Amed Co., Ltd. financials statements
Amed Co., Ltd. (7575) Ratios
Amed Co., Ltd. Ratios
TW:7575's free cash flow for Q2 2026 was NT$27.91M. For the 2026 fiscal year, TW:7575's free cash flow was decreased by NT$-12.82M and operating cash flow was NT$40.74M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.21 | 1.39 | 1.68 | 1.37 | 1.20 |
| Quick Ratio | 0.73 | 0.93 | 1.24 | 0.93 | 0.88 |
| Cash Ratio | 0.19 | 0.23 | 0.38 | 0.23 | 0.22 |
| Solvency Ratio | 0.10 | 0.13 | 0.26 | 0.22 | 0.17 |
| Operating Cash Flow Ratio | 0.04 | 0.17 | 0.40 | 0.21 | 0.19 |
| Short-Term Operating Cash Flow Coverage | 0.08 | 0.40 | 1.02 | 0.43 | 0.35 |
| Net Current Asset Value | NT$ -233.95M | NT$ -237.15M | NT$ -6.71M | NT$ -86.11M | NT$ -164.07M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.48 | 0.44 | 0.29 | 0.35 | 0.41 |
| Debt-to-Equity Ratio | 1.39 | 1.25 | 0.60 | 0.87 | 1.19 |
| Debt-to-Capital Ratio | 0.58 | 0.56 | 0.38 | 0.47 | 0.54 |
| Long-Term Debt-to-Capital Ratio | 0.42 | 0.45 | 0.25 | 0.29 | 0.37 |
| Financial Leverage Ratio | 2.88 | 2.82 | 2.08 | 2.47 | 2.88 |
| Debt Service Coverage Ratio | 0.37 | 0.61 | 1.13 | 0.78 | 0.58 |
| Interest Coverage Ratio | 6.35 | 10.26 | 18.50 | 18.05 | 13.67 |
| Debt to Market Cap | 0.61 | 0.39 | 0.12 | 0.18 | 0.17 |
| Interest Debt Per Share | 18.76 | 17.25 | 8.81 | 9.93 | 10.41 |
| Net Debt to EBITDA | 4.08 | 3.27 | 0.98 | 1.54 | 2.33 |
| Profitability Margins | |||||
| Gross Profit Margin | 64.66% | 67.30% | 68.68% | 71.91% | 73.70% |
| EBIT Margin | 9.29% | 11.41% | 16.87% | 16.18% | 13.46% |
| EBITDA Margin | 14.08% | 16.00% | 20.60% | 21.02% | 19.00% |
| Operating Profit Margin | 9.29% | 10.81% | 16.14% | 16.25% | 13.31% |
| Pretax Profit Margin | 6.80% | 10.36% | 16.00% | 15.28% | 12.48% |
| Net Profit Margin | 4.35% | 6.77% | 12.01% | 11.20% | 8.90% |
| Continuous Operations Profit Margin | 4.35% | 6.77% | 12.01% | 11.20% | 8.90% |
| Net Income Per EBT | 64.05% | 65.40% | 75.03% | 73.32% | 71.28% |
| EBT Per EBIT | 73.20% | 95.83% | 99.15% | 94.02% | 93.74% |
| Return on Assets (ROA) | 3.13% | 4.82% | 10.35% | 9.35% | 6.72% |
| Return on Equity (ROE) | 9.01% | 13.59% | 21.53% | 23.11% | 19.35% |
| Return on Capital Employed (ROCE) | 10.59% | 11.24% | 20.02% | 21.17% | 15.69% |
| Return on Invested Capital (ROIC) | 5.00% | 6.07% | 12.71% | 12.10% | 8.55% |
| Return on Tangible Assets | 3.32% | 5.14% | 11.38% | 10.48% | 7.87% |
| Earnings Yield | 4.13% | 4.39% | 4.58% | 4.91% | 2.82% |
| Efficiency Ratios | |||||
| Receivables Turnover | 3.79 | 3.60 | 3.53 | 3.43 | 3.33 |
| Payables Turnover | 15.16 | 4.11 | 13.45 | 10.63 | 7.29 |
| Inventory Turnover | 1.44 | 1.60 | 2.03 | 1.48 | 1.73 |
| Fixed Asset Turnover | 1.53 | 1.53 | 2.37 | 2.29 | 1.96 |
| Asset Turnover | 0.72 | 0.71 | 0.86 | 0.83 | 0.76 |
| Working Capital Turnover Ratio | 7.14 | 5.05 | 5.23 | 8.50 | 14.84 |
| Cash Conversion Cycle | 326.05 | 239.86 | 255.69 | 318.54 | 270.24 |
| Days of Sales Outstanding | 96.40 | 101.26 | 103.38 | 106.42 | 109.55 |
| Days of Inventory Outstanding | 253.72 | 227.43 | 179.45 | 246.45 | 210.77 |
| Days of Payables Outstanding | 24.07 | 88.83 | 27.14 | 34.33 | 50.08 |
| Operating Cycle | 350.12 | 328.69 | 282.83 | 352.87 | 320.32 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.63 | 2.09 | 3.57 | 2.07 | 1.66 |
| Free Cash Flow Per Share | -0.28 | -5.79 | 2.57 | 0.83 | -0.59 |
| Dividend Paid and CapEx Coverage Ratio | 0.26 | 0.20 | 3.55 | 1.68 | 0.74 |
| Capital Expenditure Coverage Ratio | 0.70 | 0.27 | 3.55 | 1.68 | 0.74 |
| Operating Cash Flow Coverage Ratio | 0.03 | 0.12 | 0.42 | 0.21 | 0.16 |
| Operating Cash Flow to Sales Ratio | 0.02 | 0.08 | 0.14 | 0.09 | 0.09 |
| Free Cash Flow Yield | -0.95% | -13.79% | 3.84% | 1.59% | -1.01% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 24.29 | 22.80 | 21.83 | 20.34 | 35.46 |
| Price-to-Sales (P/S) Ratio | 1.05 | 1.54 | 2.62 | 2.28 | 3.16 |
| Price-to-Book (P/B) Ratio | 2.18 | 3.10 | 4.70 | 4.71 | 6.87 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -105.00 | -7.25 | 26.02 | 62.97 | -99.07 |
| Price-to-Operating Cash Flow Ratio | 45.92 | 20.07 | 18.70 | 25.38 | 35.55 |
| Price-to-Earnings Growth (PEG) Ratio | -0.69 | -0.57 | 1.17 | 0.37 | 0.93 |
| Enterprise Value Multiple | 11.57 | 12.92 | 13.70 | 12.40 | 18.96 |
| Enterprise Value | 1.34B | 1.69B | 2.16B | 1.80B | 2.01B |
| EV to EBITDA | 11.57 | 12.92 | 13.70 | 12.40 | 18.96 |
| EV to Sales | 1.63 | 2.07 | 2.82 | 2.61 | 3.60 |
| EV to Free Cash Flow | -162.19 | -9.71 | 28.02 | 71.87 | -112.94 |
| EV to Operating Cash Flow | 70.92 | 26.88 | 20.13 | 28.97 | 40.53 |
| Tangible Book Value Per Share | 11.09 | 11.13 | 11.56 | 8.17 | 4.95 |
| Shareholders’ Equity Per Share | 13.23 | 13.54 | 14.21 | 11.14 | 8.57 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.36 | 0.35 | 0.25 | 0.27 | 0.29 |
| Revenue Per Share | 27.40 | 27.17 | 25.48 | 22.99 | 18.64 |
| Net Income Per Share | 1.19 | 1.84 | 3.06 | 2.58 | 1.66 |
| Tax Burden | 0.64 | 0.65 | 0.75 | 0.73 | 0.71 |
| Interest Burden | 0.73 | 0.91 | 0.95 | 0.94 | 0.93 |
| Research & Development to Revenue | 0.06 | 0.05 | 0.03 | 0.03 | 0.03 |
| SG&A to Revenue | 0.50 | 0.51 | 0.49 | 0.53 | 0.57 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.34 | 0.74 | 1.17 | 0.80 | 1.00 |
Currency in TWD
